<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7C9FE3A2-64B4-4511-BA18-51002CB88BE8"><gtr:id>7C9FE3A2-64B4-4511-BA18-51002CB88BE8</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Skehel</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117512711"><gtr:id>2047C1D6-A287-4875-B2BB-AC9BF243EFC1</gtr:id><gtr:title>Structure, Function, Biochemical and Immunological Properties and Biosynthesis of influenza Virus Components</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117512711</gtr:grantReference><gtr:abstractText>Influenza is a frequently recurring disease, responsible for considerable morbidity and mortality. Our studies seek to understand how the viruses that cause the disease can repeatedly infect humans and how we might more effectively prevent them from doing so by vaccination or by taking medicines. The virus protein that we mainly study is an essential part of anti-influenza vaccines and its roles in infection suggest that it could be a good target for anti-influenza drugs.</gtr:abstractText><gtr:technicalSummary>To determine the molecular basis of the functions of the Influenza virus membrane glycoprotein Haemagglutinin (HA) related to receptor binding and membrane fusion. To determine the changes in HA sequence which modify antigenicity and to investigate the molecular basis of these modifications. Routine Assays antigenic analyses by ELISA haemagglutination inhibition (HI) and immunoprecipitation using polyclonal and monoclonal antibodies; receptor binding analyses by HI and NMR spectroscopy and Biocore; membrane fusion analyses by haemolysis and resonance energy transfer. Protein Chemistry Studies of HA in different activity conformations and complexes by amino acid sequencing, mass spectrometry, circular dichroism, electron microscopy and fluorescence spectroscopy. Collaborative X-ray crystallographic studies of HA, HA fragments and HA-receptor analogue complexes and HA-monoclonal Fab complexes. Genetic manipulation of the gene for HA - site-specific mutagenesis and expression in eukaryotic cells. Recombinant vaccinia virus and Bacculovirus vectors and virus rescue following plasmid transfection. Summary: High Resolution description of receptor binding site by X-ray crystallography of mutant HAs and receptor analogue - HA complexes. High resolution description of structure of HA in membrane fusion active form resulting from X-ray crystallography of protein fragments; analysis of these fragments associated with lipid membranes by electron microscopy; site-specific mutation analyses of structural modifications required for membrane fusion and studies of membrane fusion by synthetic analogues of the fusion peptide. Descriptions of HA-neutralizing antibody interactions by site specific mutagenesis, monoclonal antibody-selected mutant studies and X-ray crystallography of HA-Fab complex crystals. Implications for improving health or health care and/or increasing wealth Influenza virus is a major cause of respiratory disease. While basic, these studies address the possibility of blocking the functions of the HA required to initiate infection and are therefore a part of antiviral research. The recurrent nature of influenza infections results from antigenic variation and our analyses of the molecular basis of this phenomenon and of the details of HA-antibody interactions are directly relevant to influenza vaccine research.</gtr:technicalSummary><gtr:fund><gtr:end>2006-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1976-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1605727</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F10F02A7-A7FB-4039-B39F-B0DB06FA0346</gtr:id><gtr:title>Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80a7be56e1751ece262fecbf341dbc5f"><gtr:id>80a7be56e1751ece262fecbf341dbc5f</gtr:id><gtr:otherNames>Yamada S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>D8262303E02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF8521CF-D8D0-4705-B8A7-5A578101ABBE</gtr:id><gtr:title>Determining the structure of an unliganded and fully glycosylated SIV gp120 envelope glycoprotein.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68f50a7040c80687a2bcb087cb28a1f9"><gtr:id>68f50a7040c80687a2bcb087cb28a1f9</gtr:id><gtr:otherNames>Chen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>F4B55BA2389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A2E4EFF-C286-4502-ACC5-FA692CB584E2</gtr:id><gtr:title>Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3429df0f1fb4f1013e2e6f82c8183d45"><gtr:id>3429df0f1fb4f1013e2e6f82c8183d45</gtr:id><gtr:otherNames>Russell RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>A6E22A5A9F8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E555FDF1-4279-45D1-9622-9D8F36116D12</gtr:id><gtr:title>High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system.</gtr:title><gtr:parentPublicationTitle>BMC biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a1363984865772a6f2ba56de89dac892"><gtr:id>a1363984865772a6f2ba56de89dac892</gtr:id><gtr:otherNames>Corral T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1472-6750</gtr:issn><gtr:outcomeId>C364B8638CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CB78764-72FA-4085-B62D-FA6310D963B6</gtr:id><gtr:title>Avian and human receptor binding by hemagglutinins of influenza A viruses.</gtr:title><gtr:parentPublicationTitle>Glycoconjugate journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3429df0f1fb4f1013e2e6f82c8183d45"><gtr:id>3429df0f1fb4f1013e2e6f82c8183d45</gtr:id><gtr:otherNames>Russell RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0282-0080</gtr:issn><gtr:outcomeId>FF831AA9A76</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DCCFD45-F4C3-4468-90F4-01B78C4F09E2</gtr:id><gtr:title>Variation and infectivity neutralization in influenza.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/103bbad731b4a20e4e5a8a47485e667f"><gtr:id>103bbad731b4a20e4e5a8a47485e667f</gtr:id><gtr:otherNames>Knossow M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>E4808B03813</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1016648C-AFF5-4A64-BC96-1DB136C56999</gtr:id><gtr:title>The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3429df0f1fb4f1013e2e6f82c8183d45"><gtr:id>3429df0f1fb4f1013e2e6f82c8183d45</gtr:id><gtr:otherNames>Russell RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>C257D2C7F02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D970CEA-0E3D-41FC-B4F4-60F00CC18D61</gtr:id><gtr:title>Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5326701fa861c5afae566266fd3de076"><gtr:id>5326701fa861c5afae566266fd3de076</gtr:id><gtr:otherNames>Collins PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>F749974EFEC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B47AC37B-F2E9-4267-B9A3-48195C6B0226</gtr:id><gtr:title>Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59f2e4bad50d6e08268e643f751aca73"><gtr:id>59f2e4bad50d6e08268e643f751aca73</gtr:id><gtr:otherNames>Thoennes S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>452C2E0719A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7165FA4-E27F-4EA5-B34C-E2124888718E</gtr:id><gtr:title>Single-particle kinetics of influenza virus membrane fusion.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61cce2dcdc90b770212858e7a5622d99"><gtr:id>61cce2dcdc90b770212858e7a5622d99</gtr:id><gtr:otherNames>Floyd DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>F4C222960C6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E05A937-00BE-4B76-92A9-E97C9FB42883</gtr:id><gtr:title>Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09401722e4d7cb68d7cee03fc7f7f3f5"><gtr:id>09401722e4d7cb68d7cee03fc7f7f3f5</gtr:id><gtr:otherNames>Mart?n D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>988BB7FF578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12C242B3-B569-4EF1-B411-C24EA3C09C0F</gtr:id><gtr:title>Infectivity studies of influenza virus hemagglutinin receptor binding site mutants in mice.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0a64d3cfffb61a92391e5f59058456d"><gtr:id>f0a64d3cfffb61a92391e5f59058456d</gtr:id><gtr:otherNames>Meisner J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>D562090704F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E061E246-78B4-405C-A4B5-0E6B448B817F</gtr:id><gtr:title>Plasticity of influenza haemagglutinin fusion peptides and their interaction with lipid bilayers.</gtr:title><gtr:parentPublicationTitle>Biophysical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa076f7747032151abedc204ba27ee59"><gtr:id>fa076f7747032151abedc204ba27ee59</gtr:id><gtr:otherNames>Vaccaro L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-3495</gtr:issn><gtr:outcomeId>E2F6EB423B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83EC6E3A-7648-409C-8E09-1AC6972B9434</gtr:id><gtr:title>Structure of an unliganded simian immunodeficiency virus gp120 core.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68f50a7040c80687a2bcb087cb28a1f9"><gtr:id>68f50a7040c80687a2bcb087cb28a1f9</gtr:id><gtr:otherNames>Chen B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>4110592B126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6117E501-9B24-474E-8A69-2D24C98C6366</gtr:id><gtr:title>Influenza a viruses with mutations in the m1 helix six domain display a wide variety of morphological phenotypes.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6627c9534fd9c69c5c6a57938823d535"><gtr:id>6627c9534fd9c69c5c6a57938823d535</gtr:id><gtr:otherNames>Burleigh LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>EBF85369116</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U117512711</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>